Anna Szumera‐Ciećkiewicz
- Oncology top 5%
- Cutaneous Melanoma Detection and Management 19
- Vascular Tumors and Angiosarcomas 12
- Cancer Immunotherapy and Biomarkers 8
- Rheumatology top 5%
- Bone Tumor Diagnosis and Treatments 15
-
- Sarcoma Diagnosis and Treatment 36
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 17
- Dermatology top 10%
-
- Chronic Lymphocytic Leukemia Research 8
-
- Cardiac tumors and thrombi 8
Anna Szumera‐Ciećkiewicz
117 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 86
- Oncology 528
- Rheumatology 203
- Pulmonary and Respiratory Medicine 415
- Pathology and Forensic Medicine 200
- Dermatology 69
Countries citing papers authored by Anna Szumera‐Ciećkiewicz
This map shows the geographic impact of Anna Szumera‐Ciećkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Szumera‐Ciećkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Szumera‐Ciećkiewicz more than expected).
Fields of papers citing papers by Anna Szumera‐Ciećkiewicz
This network shows the impact of papers produced by Anna Szumera‐Ciećkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Szumera‐Ciećkiewicz. The network helps show where Anna Szumera‐Ciećkiewicz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Szumera‐Ciećkiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 20 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 25 | |
| 18 | [The long-term treatment outcomes of adult osteosarcoma]. | 2017 | 6 |
| 19 | EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence. | 2013 | 32 |
| 20 | Endobronchial metastasis from hepatocellular carcinoma - a case description with literature review. | 2008 | 4 |
About Anna Szumera‐Ciećkiewicz
Anna Szumera‐Ciećkiewicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 127 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (36 papers), Cutaneous Melanoma Detection and Management (19 papers), Lymphoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (15 papers), Vascular Tumors and Angiosarcomas (12 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cardiac tumors and thrombi (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (528 citations), Rheumatology (203 citations) and Pulmonary and Respiratory Medicine (415 citations). Anna Szumera‐Ciećkiewicz has collaborated with scholars based in Poland, Italy and Hungary. Frequent co-authors include Piotr Rutkowski, Anna M. Czarnecka, Monika Prochorec‐Sobieszek, Mateusz Spałek, Aneta Borkowska, Konrad Ptaszyński, Paweł Teterycz, Tomasz Świtaj, Michał Wągrodzki and Hanna Koseła-Paterczyk. Their work appears in journals such as Cancers, Blood, Journal of Clinical Medicine, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.